MedTrace Logo

An Observational Study of Fungal Biomarkers (MK-0000-089)

NCT00854607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2015-08-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the relationship between fungal biomarker levels during anti-fungal therapy and the success of treatment for fungal infection. The primary hypothesis is that over the initial two weeks of anti-fungal therapy, fungal biomarkers from participants with invasive aspergillosis (IA) will be lower for those with a successful clinical outcome compared to those with a failed clinical outcome.

Conditions

  • Aspergillosis

Interventions

OTHER

No Intervention

Blood samples will be collected for 12 weeks to evaluate levels of fungal biomarkers.

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-06-30
Completion
2011-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00854607 on ClinicalTrials.gov